Diabetes

Filter

AI and Wearable Tech can Predict Diabetes Risk Before Symptoms

August 2025

Discover how new AI can spot hidden diabetes risk earlier than ever before. Keep reading for the full story.

Oral Semaglutide Lowers Cardiovascular Risk in Type 2 Diabetes, with or without SGLT2i

Oral semaglutide reduces cardiovascular events in type 2 diabetes, independent of SGLT2i therapy, with no safety concerns.

Study Shows Mobile Health Intervention Feasible for Type 2 Diabetes Patients

A study has demonstrated the feasibility of a mobile health-supported home-delivered physical activity programme for individuals recently diagnosed with Type 2 diabetes.

Type 2 Diabetes vs. Hypertension: Which Has a Greater Impact on Kidney Damage?

A recent study explored impact of hypertension and type 2 diabetes on kidney structure, revealing similar damage in both conditions.

Semaglutide Linked to NAION Risk in Patients with Diabetes

Semaglutide use in diabetic patients linked to increased risk of NAION after two years of treatment.

Is Gestational Diabetes Risk Reduced by High Protein Diet?

New research shows that animal and total protein intake could reduce the risk of gestational diabetes during pregnancy.

Predictive Model Optimises Treatment Selection for Type 2 Diabetes

A new predictive model helps personalise glucose-lowering therapy for type 2 diabetes, improving glycaemic control and reducing complications.

The Role of Sleep Quality in Geriatric Type 2 Diabetes Management

Poor sleep quality in geriatric type 2 diabetes patients is linked to worse glycaemic control and complications.

Automated Insulin Delivery Improves Glycaemic Control in Type 2 Diabetes

Research suggests that automated insulin delivery (AID) systems may play a significant role in enhancing glucose management.

Loading posts...

« Previous 1 … 5 6 7 8 9 … 36 Next »